Not everyday investors get to experience a company’s share climbing at a rate of 54%. According to reports, the shares of Cocrystal Pharma Inc (OTCBB:COCP) have increased significantly well over the past few days. COCP’s performance proved to be a great example for those who thought that it was not a good option to invest.
Factors That Drove COCP On A Growing Path:
One factor that drives share prices is the eagerness of shareholders to buy that stock. In COCP’s case, shareholders found it the perfect option to buy because of the recent announcement made by the company. COCP has been working on developing a cure for one of the deadly diseases of the world named Hepatitis C. Each year, hundreds of thousands of people die due to lack of resources and absence of proper cure of this disease. The company doesn’t want to leave any stone unturned; hence, it has put the best available group of subject matter experts to develop the cure for Hepatitis C. This team is being led by the founder of Pharmasset. According to reports, COCP’s initiative towards developing Hepatitis C antiviral has been appreciated by all the investors.
Another factor that helped COCP witness second to none growth rate was Dr. Phillip Frost’s decision to leave Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) where he was working lately. Frost is the Director of COCP and holds key positions in many other companies. Due to this extra burden, he was not able to focus on his responsibilities in TEVA; hence, he decided to leave the company with immediate effect. There are rumors that he will actively participate in the proceedings of COCP now and help the company in touching new heights.
The two news hit the digital as well as print media in a matter of a couple of days and helped the company moving towards a milestone that was never touched before.